BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34339420)

  • 1. Kidney organoids generated from erythroid progenitors cells of patients with autosomal dominant polycystic kidney disease.
    Facioli R; Lojudice FH; Anauate AC; Maquigussa E; Nishiura JL; Heilberg IP; Sogayar MC; Boim MA
    PLoS One; 2021; 16(8):e0252156. PubMed ID: 34339420
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kuraoka S; Tanigawa S; Taguchi A; Hotta A; Nakazato H; Osafune K; Kobayashi A; Nishinakamura R
    J Am Soc Nephrol; 2020 Oct; 31(10):2355-2371. PubMed ID: 32747355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ADPKD model using kidney organoids derived from disease-specific human iPSCs.
    Shimizu T; Mae SI; Araoka T; Okita K; Hotta A; Yamagata K; Osafune K
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1186-1194. PubMed ID: 32819584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
    Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD.
    Mae SI; Hattanda F; Morita H; Nozaki A; Katagiri N; Ogawa H; Teranaka K; Nishimura Y; Kudoh A; Yamanaka S; Matsuse K; Ryosaka M; Watanabe A; Soga T; Nishio S; Osafune K
    Cell Rep; 2023 Dec; 42(12):113431. PubMed ID: 38039961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.
    Kenter AT; Rentmeester E; van Riet J; Boers R; Boers J; Ghazvini M; Xavier VJ; van Leenders GJLH; Verhagen PCMS; van Til ME; Eussen B; Losekoot M; de Klein A; Peters DJM; van IJcken WFJ; van de Werken HJG; Zietse R; Hoorn EJ; Jansen G; Gribnau JH
    Stem Cells Transl Med; 2020 Apr; 9(4):478-490. PubMed ID: 32163234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of infant- and pediatric-derived urinary induced pluripotent stem cells competent to form kidney organoids.
    Mulder J; Sharmin S; Chow T; Rodrigues DC; Hildebrandt MR; D'Cruz R; Rogers I; Ellis J; Rosenblum ND
    Pediatr Res; 2020 Mar; 87(4):647-655. PubMed ID: 31629364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional in vitro models answer the right questions in ADPKD cystogenesis.
    Dixon EE; Woodward OM
    Am J Physiol Renal Physiol; 2018 Aug; 315(2):F332-F335. PubMed ID: 29693448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1.
    Huang CY; Ho MC; Lee JJ; Hwang DY; Ko HW; Cheng YC; Hsu YH; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Oct; 24():139-143. PubMed ID: 29034881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an induced pluripotent stem cell line, IBMS-iPSC-014-05, from a female autosomal dominant polycystic kidney disease patient carrying a common mutation of R803X in PKD2.
    Ho MC; Huang CY; Lee JJ; Hsu SH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():38-41. PubMed ID: 29055226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid target validation in a Cas9-inducible hiPSC derived kidney model.
    Shamshirgaran Y; Jonebring A; Svensson A; Leefa I; Bohlooly-Y M; Firth M; Woollard KJ; Hofherr A; Rogers IM; Hicks R
    Sci Rep; 2021 Aug; 11(1):16532. PubMed ID: 34400685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human induced pluripotent stem cell line (BCRTi007-A) from urinary cells of a patient with autosomal dominant polycystic kidney disease.
    Batool L; Raab C; Beez CM; Kurtz A; Gollasch M; Rossbach B
    Stem Cell Res; 2023 Jun; 69():103071. PubMed ID: 36947994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of induced pluripotent stem cell PLAFMCi002-A derived from peripheral blood mononuclear cells of polycystic kidney disease patient with PKD1 mutation.
    Wang T; Li J; Xiao Y; Fu B; Wang P; Bai X; Cai G; Chen X; Li Q
    Stem Cell Res; 2020 Dec; 49():102039. PubMed ID: 33068887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms.
    Forbes TA; Howden SE; Lawlor K; Phipson B; Maksimovic J; Hale L; Wilson S; Quinlan C; Ho G; Holman K; Bennetts B; Crawford J; Trnka P; Oshlack A; Patel C; Mallett A; Simons C; Little MH
    Am J Hum Genet; 2018 May; 102(5):816-831. PubMed ID: 29706353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with
    Linn AK; Maneepitasut W; Tubsuwan A; Kitiyanant N; Phakdeekitcharoen B; Borwornpinyo S; Hongeng S; Phanthong P
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation.
    Lee JJ; Ho MC; Huang CY; Wen CH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():83-87. PubMed ID: 29121521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying cystogenic paracrine signaling molecules in cyst fluid of patients with polycystic kidney disease.
    Kenter AT; van Rossum-Fikkert SE; Salih M; Verhagen PCMS; van Leenders GJLH; Demmers JAA; Jansen G; Gribnau J; Zietse R; Hoorn EJ
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F204-F213. PubMed ID: 30403162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease.
    Cruz NM; Song X; Czerniecki SM; Gulieva RE; Churchill AJ; Kim YK; Winston K; Tran LM; Diaz MA; Fu H; Finn LS; Pei Y; Himmelfarb J; Freedman BS
    Nat Mater; 2017 Nov; 16(11):1112-1119. PubMed ID: 28967916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-β inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells.
    Elberg D; Jayaraman S; Turman MA; Elberg G
    Exp Cell Res; 2012 Aug; 318(13):1508-16. PubMed ID: 22504005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.